Texas Instruments (TXN) Stock Rockets 16% on Outstanding First Quarter Results
Texas Instruments (TXN) stock soars 16% after beating Q1 estimates with $1.68 EPS. Analysts raise targets to $330 on Industrial an...
Alphabet (GOOGL) Stock Surges on TPU 8i Reveal: Cramer Eyes $400 Target
Alphabet (GOOGL) shares jumped 2.1% after TPU 8i AI chip launch. Cramer targets $400, while Wall Street consensus reaches $387.68...
Stock Market Tumbles as IBM and ServiceNow Earnings Disappoint While Oil Surges...
Markets declined Thursday as IBM fell 10% and ServiceNow dropped 15% post-earnings. Oil hit $102 on Iran tensions while Texas Inst...
Tilray (TLRY) Stock Rockets 14% on Trump Cannabis Rescheduling News
Tilray (TLRY) stock jumped 14.2% Wednesday as Axios reported Trump's White House may reclassify cannabis to Schedule III, sparking...
Super Micro Computer (SMCI) Stock Plummets 10% After Oracle Cancels Massive AI S...
Super Micro (SMCI) stock tumbles 10% as Oracle reportedly cancels $1.4B AI rack order. Co-founder faces federal charges over chip...
Lockheed Martin (LMT) Shares Slide 3% Following Q1 Earnings Shortfall and Unchan...
Lockheed Martin (LMT) stock declined approximately 3% after reporting Q1 EPS of $6.44, missing estimates, and keeping FY26 revenue...
Freeport-McMoRan (FCX) Stock Plunges 10% After Slashing Production Forecasts
Freeport-McMoRan (FCX) stock plunged 10% despite strong Q1 results after the company reduced 2026 copper and gold forecasts due to...
Applied Digital (APLD) Stock Rallies 12% on Massive $7.5B Hyperscaler Agreement
Applied Digital (APLD) stock rallied 12% after announcing a $7.5B hyperscaler lease deal at Delta Forge 1, pushing total contracte...
Leidos (LDOS) Secures $617M Army Contract for Air Defense Systems
Leidos (LDOS) secures $617M U.S. Army contract for air defense launchers, bringing IFPC Inc 2 program total to nearly $1.2B with 1...
Novo Nordisk (NVO) Stock Rises After Pediatric Diabetes Drug Trial Success
Novo Nordisk (NVO) stock gains after oral semaglutide pill succeeds in pediatric type 2 diabetes trial. Company targets H2 2026 fi...